-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pancreatic neuroendocrine tumors (PanNENs) are a group of heterogeneous tumors with different clinical and pathological characteristics, produced by neuroendocrine cells and accounting for 1-3%
The purpose of the new classification is to guide the clinical development of appropriate treatment strategies and patient care, and to improve the prediction
Recently, a study published in the European Journal of Radiology accurately identified PNECs and G1/2/3 PNETs by evaluating quantitative indicators of enhanced CT, providing technical support and reference for accurate clinical treatment planning and predictive prognosis
This study retrospectively included 17 patients with PNECs and 131 patients with biopsy or surgically confirmed PNETs
In this study, the mean artery/portal vein absolute enhancement values of PNECs (19.
This study shows that quantitative parameters of enhanced CT can be used for the differential diagnosis of PNECs and PNETs, where artery/portal absolute enhancement values are independent predictors with good diagnostic accuracy
Original source:
Hai-Yan Chen,Yao Pan,Jie-Yu Chen,et al.